United States · 
Who invested in Phase Genomics?
Phase Genomics's investors include Citibank, National Institutes of Health, Congruent Ventures, Four Cities Capital and National Institute of Allergy and Infectious Diseases.
United States · Funded startup
Who invested in Phase Genomics
Funding summaryUpdated 26 Oct 2026
$1.5Mraised across 1 round since 2024, from 1 source
- Latest round
- Grant, $1.5MMar 2024
- Investors
- 5
The rounds
- Mar 2024
Founders and team
From Phase Genomics's own website and the SEC filings it signed: 1 founder, 3 on the team.
Ivan LiachkoFounder & CEONamed on its 2023 Form D
- Kayla YoungCOO
- Stephen EackerVP of Research & Development
- Shawn SullivanExecutive Officer, Promoteri
AdvisersKen Myer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 3 firms list Phase Genomics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Phase Genomics
How much has Phase Genomics raised?
Phase Genomics has raised $1.5M across 1 round since 2024.
When did Phase Genomics last raise?
Phase Genomics's most recent round was a Grant of $1.5M in Mar 2024.
What was Phase Genomics's biggest round?
Its most recent round, $1.5M in Mar 2024, is also its largest on record.
Who backed Phase Genomics first?
Phase Genomics's first round on record, in Mar 2024, was backed by Citibank, National Institutes of Health and Congruent Ventures and 2 others.
What stage is Phase Genomics at?
Phase Genomics's latest named round is a Grant, in Mar 2024.
Where is Phase Genomics based?
Phase Genomics is based in the United States.
Companies like Phase Genomics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.